Basic Information
RNALocate ID: | RLID:11003000 |
RNA Symbol: | hsa-miR-495-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-495-3p |
RNA ID: | miRBase:MIMAT0002817 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 24683445 |
Tissue/Cell Line: | Plasma |
Method: | Next-generation RNA sequencing |
Description: | Exosomes are enriched with miRNA: Small RNA libraries of the samples described above were constructed for small RNA-seq by NGS. The number of miRNA identified in this study was 943 of 2,233 known mature miRNA from miRBase V.20. Mapping to Ensembl Release 74 was performed to identify other non-coding RNA such as tRNA, rRNA, small nucleolar RNA (snoRNA) and LincRNA. The average across all 3 samples was calculated to obtain a representative profile of biological diversity between patients (standard deviations of reads in Supplementary file). |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01002337 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:11002998 | Exosome | Brain tissue | 23382797 |
RLID:11002999 | Exosome | Plasma | 23663360 |
RLID:11003001 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000484 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine | |
RLID-D:11001249 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-495-3p | Oral squamous cell carcinoma | MNDR-E-MI-54671 |
MNDR | hsa-miR-495-3p | Medulloblastoma | MNDR-E-MI-54672 |
MNDR | hsa-miR-495-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-54673 |
MNDR | hsa-miR-495-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-54674 |
MNDR | hsa-miR-495-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-54675 |
MNDR | hsa-miR-495-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-54676 |
MNDR | hsa-miR-495-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-54677 |
MNDR | hsa-miR-495-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-54678 |
MNDR | hsa-miR-495-3p | Her2-receptor positive breast cancer | MNDR-E-MI-54679 |
MNDR | hsa-miR-495-3p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-54680 |
MNDR | hsa-miR-495-3p | Autosomal recessive limb-girdle muscular dystrophy type 2b | MNDR-E-MI-54681 |
MNDR | hsa-miR-495-3p | Dermatomyositis | MNDR-E-MI-54682 |
MNDR | hsa-miR-495-3p | Prostate cancer | MNDR-E-MI-54683 |
MNDR | hsa-miR-495-3p | Gastric cancer | MNDR-E-MI-54684 |
MNDR | hsa-miR-495-3p | Alzheimer disease | MNDR-E-MI-54685 |
MNDR | hsa-miR-495-3p | Bladder cancer | MNDR-E-MI-54686 |
MNDR | hsa-miR-495-3p | Esophageal carcinoma | MNDR-E-MI-54687 |
MNDR | hsa-miR-495-3p | Dysautonomia familial | MNDR-E-MI-54688 |
MNDR | hsa-miR-495-3p | Distal muscular dystrophy | MNDR-E-MI-54689 |
MNDR | hsa-miR-495-3p | Duchenne muscular dystrophy | MNDR-E-MI-54690 |
MNDR | hsa-miR-495-3p | Leukemia | MNDR-E-MI-54691 |
MNDR | hsa-miR-495-3p | Cardiovascular disease | MNDR-E-MI-54692 |
MNDR | hsa-miR-495-3p | Dilated cardiomyopathy | MNDR-E-MI-54693 |
MNDR | hsa-miR-495-3p | Lung cancer | MNDR-E-MI-54694 |
MNDR | hsa-miR-495-3p | Endometrial cancer | MNDR-E-MI-54695 |
MNDR | hsa-miR-495-3p | Parkinson disease | MNDR-E-MI-54696 |
MNDR | hsa-miR-495-3p | Breast cancer | MNDR-E-MI-54697 |
MNDR | hsa-miR-495-3p | Squamous cell carcinoma | MNDR-E-MI-54698 |
MNDR | hsa-miR-495-3p | Thyroid cancer | MNDR-E-MI-54699 |
MNDR | hsa-miR-495-3p | Pancreatic cancer | MNDR-E-MI-54700 |
MNDR | hsa-miR-495-3p | Melanoma | MNDR-E-MI-54701 |
MNDR | hsa-miR-495-3p | Nephroblastoma | MNDR-E-MI-54702 |
MNDR | hsa-miR-495-3p | Colon cancer | MNDR-E-MI-54703 |
MNDR | hsa-miR-495-3p | Colon adenocarcinoma | MNDR-E-MI-54704 |
MNDR | hsa-miR-495-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-54705 |
MNDR | hsa-miR-495-3p | Familial ovarian cancer | MNDR-E-MI-54706 |
MNDR | hsa-miR-495-3p | Prostate adenocarcinoma | MNDR-E-MI-54707 |
MNDR | hsa-miR-495-3p | Carcinoma ductal breast | MNDR-E-MI-54708 |
MNDR | hsa-miR-495-3p | Glioblastoma | MNDR-E-MI-54709 |
MNDR | hsa-miR-495-3p | Malignant glioma | MNDR-E-MI-54710 |
MNDR | hsa-miR-495-3p | Nemaline myopathy | MNDR-E-MI-54711 |
MNDR | hsa-miR-495-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-54712 |
MNDR | hsa-miR-495-3p | Temporal lobe epilepsy | MNDR-E-MI-54713 |
MNDR | hsa-miR-495-3p | Osteosarcoma | MNDR-E-MI-54714 |
MNDR | hsa-miR-495-3p | Coronary artery disease | MNDR-E-MI-54715 |
MNDR | hsa-miR-495-3p | Breast carcinoma | MNDR-E-MI-54716 |
MNDR | hsa-miR-495-3p | Gastric adenocarcinoma | MNDR-E-MI-54717 |
MNDR | hsa-miR-495-3p | Cervical squamous cell carcinoma | MNDR-E-MI-54718 |
MNDR | hsa-miR-495-3p | Bone-invasive pituitary adenoma | MNDR-E-MI-54719 |
MNDR | hsa-miR-495-3p | Carcinoma lung non-small-cell | MNDR-E-MI-54720 |
MNDR | hsa-miR-495-3p | Adrenocortical carcinoma | MNDR-E-MI-54721 |
MNDR | hsa-miR-495-3p | Thyroid carcinoma | MNDR-E-MI-54722 |
MNDR | hsa-miR-495-3p | Ovarian carcinoma | MNDR-E-MI-54723 |
MNDR | hsa-miR-495-3p | Bladder urothelial carcinoma | MNDR-E-MI-54724 |
MNDR | hsa-miR-495-3p | Pancreatic adenocarcinoma | MNDR-E-MI-54725 |
MNDR | hsa-miR-495-3p | Carcinoma renal cell | MNDR-E-MI-54726 |
MNDR | hsa-miR-495-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-54727 |
MNDR | hsa-miR-495-3p | Renal clear cell carcinoma | MNDR-E-MI-54728 |
MNDR | hsa-miR-495-3p | Cholangiocarcinoma | MNDR-E-MI-54729 |
MNDR | hsa-miR-495-3p | Lung small cell carcinoma | MNDR-E-MI-54730 |
MNDR | hsa-miR-495-3p | Synovial sarcoma | MNDR-E-MI-54731 |
MNDR | hsa-miR-495-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-54732 |
MNDR | hsa-miR-495-3p | Breast invasive carcinoma | MNDR-E-MI-54733 |
MNDR | hsa-miR-495-3p | Familiar ovarian carcinoma | MNDR-E-MI-54734 |
MNDR | hsa-miR-495-3p | Periodontitis | MNDR-E-MI-54735 |
MNDR | hsa-miR-495-3p | Salivary gland cancer | MNDR-E-MI-54736 |
MNDR | hsa-miR-495-3p | Acute myeloid leukemia with mixed lineage leukemia | MNDR-E-MI-54737 |
MNDR | hsa-miR-495-3p | Colorectal cancer | MNDR-E-MI-54738 |
MNDR | hsa-miR-495-3p | Nasopharynx carcinoma | MNDR-E-MI-54739 |
MNDR | hsa-miR-495-3p | Ovarian epithelial cancer | MNDR-E-MI-54740 |
MNDR | hsa-miR-495-3p | Nasopharyngeal cancer | MNDR-E-MI-54741 |
MNDR | hsa-miR-495-3p | Aids dementia complex | MNDR-E-MI-54742 |
MNDR | hsa-miR-495-3p | Muscular disorders atrophic | MNDR-E-MI-54743 |
MNDR | hsa-miR-495-3p | Breast cancer her3+ negative | MNDR-E-MI-54744 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022790 |
TOP